Basic Information
| LncRNA/CircRNA Name | ANRIL |
| Synonyms | CDKN2B-AS1, ANRIL, CDKN2B-AS, CDKN2BAS, NCRNA00089, PCAT12, p15AS |
| Region | GRCh38_9:21994778-22121097 |
| Ensemble | ENSG00000240498 |
| Refseq | NR_003529 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | colon cancer |
| ICD-0-3 | C18 |
| Methods | qPCR, RNAi, Western blot, ChIP, Luciferase reporter assay, Cell proliferation assay etc. |
| Sample | cell lines (HCT116, U2OS) |
| Expression Pattern | up-regulated |
| Function Description | The results showed that cell proliferation was substantially retarded in the ANRIL-knockdown cells compared to the control cells, while the cells overexpressing ANRIL exhibited accelerated proliferation. In untreated HCT116 p53+/+ cells, overexpression of ANRIL appeared to promote DNA synthesis and cell proliferation evidenced by the higher percentage of S-phase cells. |
| Pubmed ID | 23416462 |
| Year | 2013 |
| Title | Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway. |
External Links
| Links for ANRIL | GenBank HGNC NONCODE |
| Links for colon cancer | OMIM COSMIC |